Clinical Trials Browser

OTHER × Gastroesophageal Junction Adenocarcinoma × Gastrointestinal × Clear all

NCT04656041 2025-11-14

Folfox+Irinotecan+Chemort In Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Gastroesophageal Junction Adenocarcinoma

NCT01962246 2022-02-21

A-C

Phase 2/3 Completed

Gastrointestinal

Gastroesophageal Junction Adenocarcinoma